Brivanib (BMS) fails Phase III trial for Hepatocellular Carcinoma - 21-Jul-2012
Bristol Myers Squibb (BMS) announced the results of the phase III BRISK-FL clinical trial of the investigational agent brivanib versus sorafenib as first-line treatment in patients with advanced Hepatocellular Carcinoma (liver cancer). The study did not meet its primary overall survival objective based upon a non-inferiority statistical design. BMS is considering options for the ongoing brivanib development program. Ongoing clinical trials of brivanib, which include Hepatocellular Carcinoma as well as other tumor types, will continue at the present time.
Related News
ThermoDox (Celsion) fails Phase III trial for Liver Cancer
Phase II success for resminostat (4SC) in Liver Cancer
No benefit of Tarceva (Genentech/Roche) for patients with Liver Cancer
Brivanib (BMS) fails Phase III trial for Hepatocellular Carcinoma
Tivantinib (Daiichi Sankyo.) in Phase II study of Hepatocellular Carcinoma
New Europe-focused Phase III Trial of TheraSphere (Nordion) for Liver Cancer
Decalth PHP brings benefits to patients with Liver Cancer
Fasiglifam (Takeda) success in Phase III trial for treatment of Type 2 Diabetes
Related Oncology Information
Oncology Clinical Guidelines
Familial breast cancer: The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care
NICEProstate cancer: diagnosis and treatment
NICEOncology Clinical Trials
Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer
Clinicaltrials.gov 08 April 2013Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy (CONKO-007)
Clinicaltrials.gov 04 April 2013Oncology Medical Journal Abstracts
Bone mass density, fracture history, self-reported osteoporosis as proxy variables for estrogen and the risk of non-small-cell lung cancer—A population based cohort study, the HUNT study: Are proxy variables friends or faults?
Lung Cancer 24 April 2013Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: A systematic review with meta-analysis
Lung Cancer 22 April 2013Oncology Medical Apps
CCO Oncology inPractice
Free
Cancer Signs and Symptoms
Free
Related Oncology Drugs
- JEVTANA
- CYPROSTAT 50MG
- LEUKERAN TABLETS 2 MG
- PROSTAP SR DCS
- TAXOTERE 80MG/4ML CONCENTRATE FOR SOLUTION FOR INFUSION
- ATRIANCE 5 MG/ML SOLUTION FOR INFUSION
- HYDREA 500 MG HARD CAPSULES
- VEPESID SOFT CAPSULES 50 MG AND 100 MG
- CAMPTO 20MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- UTOVLAN
- TAMOFEN (CARCINOMA)
- TEMODAL CAPSULES
- BICALUTAMIDE 50MG FILM-COATED TABLETS
- REVLIMID
- FASLODEX 250 MG SOLUTION FOR INJECTION
- VESANOID 10MG SOFT CAPSULES
- HYCAMTIN 0.25MG AND 1 MG HARD CAPSULE
- TOMUDEX
- GLIADEL 7.7MG IMPLANT
- NOVGOS
- LEVOFOLINIC ACID 50 MG/ML SOLUTION FOR INJECTION OR INFUSION
- TAXOL
- CARBOPLATIN 10MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- MABTHERA 100MG AND 500MG CONCENTRATE FOR SOLUTION FOR INFUSION
- XALUPRINE
- TASIGNA 200 MG HARD CAPSULES
- KYTRIL TABLETS 1MG AND 2MG
- VOTRIENT 200 MG AND 400 MG FILM COATED TABLETS
- BICALUTAMIDE 150MG FILM-COATED TABLETS
- YONDELIS SOLUTION FOR INFUSION.
- CARDIOXANE 500MG POWDER FOR SOLUTION FOR INFUSION
- PROSTAP 3 DCS
- XELODA 150MG AND 500MG FILM-COATED TABLETS
- MITOMYCIN C
- FIRMAGON 120MG INJECTION
- VOTRIENT 200 MG FILM-COATED TABLETS
- MEGACE 160 MG TABLETS
- CAELYX 2MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- FLUOROURACIL 25 MG/ML INJECTION
- ZAVEDOS
- TYVERB
- ZOLADEX
- VELCADE 3.5 MG POWDER FOR SOLUTION FOR INJECTION.
- CYTARABINE INJECTION SOLUTION 20MG/ML AND 100MG/ML
- MAXTREX TABLETS 2.5 MG
- PROVERA TABLETS 100 MG
- NASTROSA 1MG FILM-COATED TABLETS
- SPRYCEL 20MG, 50MG, 80MG, 100MG AND 140MG FILM COATED TABLETS
- FIRMAGON 80MG INJECTION
- CASODEX 150 MG FILM-COATED TABLETS.
- CYCLOPHOSPHAMIDE 50 TABLETS
- CASODEX 50 MG FILM-COATED TABLETS
- EFUDIX CREAM
- ROFERON-A PRE-FILLED SYRINGE
- ZALTRAP 25MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- MITOXANTRONE (MITOZANTRONE) 2 MG/ML STERILE CONCENTRATE
- UFTORAL HARD CAPSULES
- GLIVEC
- AVASTIN 25MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- ROFERON-A 18MIU/0.6ML CARTRIDGE
- NAVELBINE 10 MG / ML CONCENTRATE FOR SOLUTION FOR INFUSION
- IRESSA 250MG FILM-COATED TABLETS
- TAXOTERE 20MG/1ML CONCENTRATE FOR SOLUTION FOR INFUSION
- ARIMIDEX 1MG FILM-COATED TABLET
- MYOCET
- ONCOTICE
- VOTRIENT 200 MG FILM-COATED TABLETS
- PROCARBAZINE CAPSULES 50MG
- ISOVORIN
- PARAPLATIN
- HALAVEN 0.44 MG/ML SOLUTION FOR INJECTION
- ELOXATIN 5 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- NIPENT 10 MG POWDER FOR SOLUTION FOR INJECTION, POWDER FOR SOLUTION FOR INFUSION
- DOXORUBICIN 2MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- VINCRISTINE SULPHATE 1 MG/ML INJECTION
- TEPADINA 100 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- VINBLASTINE SULPHATE 1 MG/ML INJECTION
- ERWINASE
- FLUDARA ORAL 10 MG FILM-COATED TABLET
- SUTENT 12.5MG, 25MG, 37.5MG AND 50MG HARD CAPSULES
- SOLTAMOX
- XAGRID 0.5MG HARD CAPSULE
- GEMZAR 200MG POWDER FOR SOLUTION FOR INFUSION, GEMZAR 1000MG POWDER FOR SOLUTION FOR INFUSION
- DACARBAZINE 100MG, 200MG, 500MG, 1000MG
- TARCEVA 25MG, 100MG AND 150MG FILM-COATED TABLETS
- HYCAMTIN 1MG AND 4MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- PROSTAP 3 LEUPRORELIN ACETATE DEPOT INJECTION 11.25MG
- HERCEPTIN 150MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- PHOTOFRIN
- TOPOTECAN 4 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- ONKOTRONE INJECTION
- TAXCEUS 20MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- PROLEUKIN
- TESTOSTERONE ENANTATE AMPOULES
- CYPROSTAT 100MG
- GRANISETRON
- ERBITUX 5MG/ML SOLUTION FOR INFUSION
- AROMASIN
- LEUSTAT INJECTION
- GEMCITABINE 200 MG POWDER FOR SOLUTION FOR INFUSION / GEMCITABINE 1 G POWDER FOR SOLUTION FOR INFUSION / GEMCITABINE 2 G POWDER FOR SOLUTION FOR INFUSION
- PROSTAP SR
- PERJETA 420 MG CONCENTRATE FOR SOLUTION FOR INFUSION
- DAUNOXOME INJECTION (LIPOSOMAL DAUNORUBICIN)
- PHARMORUBICIN
- FEMARA
- TAXOTERE 160MG/8ML CONCENTRATE FOR SOLUTION FOR INFUSION
- ESTRACYT CAPSULES
- ETOPOPHOS 100MG POWDER FOR SOLUTION FOR INJECTION
- MAXTREX TABLETS 10 MG
- FARESTON
- EVOLTRA 1MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- NEXAVAR 200MG FILM-COATED TABLETS
Advert for Healthcare Professionals only